A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer

计划入组 64 人 · 首次发布于 2013 年 2 月 15 日

A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer

计划入组 42 人 · 首次发布于 2013 年 3 月 18 日

A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer

计划入组 58 人 · 首次发布于 2011 年 2 月 21 日

BIND-267

BIND-014

BIND-747

Bind Therapeutics

United States

BINH DAN HOSPITAL

Vietnam

B.J. Bink Beheer B.V.

Netherlands

APOE-Stratified GWAS Uncovers New Alzheimer's Risk Loci and Supports A Priori APOE Stratification in AD Trials

Pin1 Inhibitors Demonstrate Novel Antiviral Mechanism Against HSV-1 by Trapping Virus in Cell Nucleus